Oropharynx Squamous Cell Carcinoma — Trials

Oropharynx Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: Aveta Biomics, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04359199	QUantitative Assessment of Swallowing After Radiation (QUASAR)(QUASAR)	unknown	—	42	Loren Mell, MDOTHER	1	Feb 10, 2023	clinicaltrials
NCT02663583	Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell	unknown	—	44	M.D. Anderson Cancer CenterOTHER	1	May 23, 2019